代表性成果
1、Zhu A#, Chen Z#, Yan Q#, Jiang M#, Liu X#, Li Z#, Li N#, Tang C#, Jian W#, He J, Chen L, Cheng J, Chen C, Tang T, Xu Z, Hu Q, Li F, Wang Y, Sun J, Zhuang Z, Wen L, Zhuo J, Liu D, Zhang Y, Huang X, Li S, Zeng Q, Chen F, Zhou L, Liu D, Zhong C, Chen Y, Li S, Liang K, Zhong N, Zhang X, Chen J, Chen X*, Xu Y*, Zhong N*, Zhao J*, Zhao J*. Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs. Nat Immunol. 2025 Mar;26(3):459-472. (IF=27.7)
2、Wang Y#, Cai R#, Zhu A#, Chen J, Chen C, Zhou L, Xing X, Zhong Q, Wei P, Li X, Zhang Z, Zhang Y, Chen L, Gao J, Li S, Xiong X, Qu B, Huang S, Lin Z, Bai H, Hu Q, Zhao J, Shi Y, Yang Y, Qin P, Zhang L, Zhao J. Immune profiling of mpox survivors reveals divergent durability of antibody and T cell responses. Nat Commun. 2025 Dec 4. doi: 10.1038/s41467-025-67266-7. Epub ahead of print. PMID: 41345407. (IF=15.7)
3、Zhang J#, Zhu A#, Wei S, Shi Y, Chen C, Huang T, Tang T, Zhao J, Cai Y, Han C, Zhao J, Wang Y. Identification of Pan-Coronavirus Neutralizing Aptamers Through CRISmers Targeting the Conserved Fusion Peptide. Adv Healthc Mater. 2025 Aug;14(21):e2501869. (IF=9.6)
4、Chen Z#, Yuan Y#, Hu Q#, Zhu A#, Chen F, Li S, Guan X, Lv C, Tang T, He Y, Cheng J, Zheng J, Hu X, Zhao J*, Zhao J*, Sun J*. SARS-CoV-2 immunity in animal models. Cell Mol Immunol. 2024 Feb;21(2):119-133. (IF=21.8)
5、Zhao H#, Zhang NN#, Hannawi S#, Zhu AR#, Xiong XC, Huang YJ, Yu DD, Chen CJ, Dai J, Abuquta A, Ying B*, Zhao JC*, Qin CF*. Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine. Cell Discov. 2024 Jan 9;10(1):7. (IF=13.0)
6、Zhu A#, Wei P#, Man M#, Liu X#, Ji T#, Chen J, Chen C, Huo J*, Wang Y*, Zhao J*. Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2. Signal Transduct Target Ther. 2023 Mar 15;8(1):125. (IF=52.7)
7、Qiu S#, Chen Z#, Zhu A#, Zeng Q#, Liu H#, Liu X, Ye F, Jin Y, Wu J, Yang C, Wang Q, Chen F, Chen L, Tian S, Du X, Hu Q, Cheng J, Chen C, Li F, Sun J, Wang Y, Zhao J*, Zhao J*, Song H*. Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine. Signal Transduct Target Ther. 2023 Mar 15;8(1):123. (IF=52.7)
8、Zhang J#, Zhu A#, Mei M, Qu J, Huang Y, Shi Y, Xue M, Zhang J, Zhang R*, Zhou B*, Tan X*, Zhao J*, Wang Y*. Repurposing CRISPR/Cas to Discover SARS-CoV-2 Detecting and Neutralizing Aptamers. Adv Sci (Weinh). 2023 Aug;10(22):e2300656. (IF=14.3)
9、Liu D#, Chen C#, Chen D#, Zhu A#, Li F#, Zhuang Z, Mok CKP, Dai J, Li X, Jin Y, Chen Z, Sun J, Wang Y, Li Y, Zhang Y, Wen L, Zhang Z, Zhuo J, Wang J, Ran W, Wang D, Zhang S, Tang Y, Li S, Lai X, Wei P, Yuan J, Chen F, Huang S, Sun F, Qian Z, Tan W, Zhao J*, Peiris M*, Zhao J*. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2. Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2202820120. (IF=9.4)
10、Mok CKP#, Zhu A#, Zhao J#, Lau EHY, Wang J, Chen Z, Zhuang Z, Wang Y, Alshukairi AN, Baharoon SA, Wang W, Tan W, Liang W, Oladipo JO, Perera RAPM, Kuranga SA, Peiris M*, Zhao J*. T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study. Lancet Infect Dis. 2021 Mar;21(3):385-395. (IF=36.4)
11、Sun J#, Zhu A#, Li H#, Zheng K#, Zhuang Z#, Chen Z#, Shi Y#, Zhang Z#, Chen SB#, Liu X#, Dai J, Li X, Huang S, Huang X, Luo L, Wen L, Zhuo J, Li Y, Wang Y, Zhang L, Zhang Y, Li F, Feng L, Chen X, Zhong N, Yang Z*, Huang J*, Zhao J*, Li YM*. Isolation of Infectious SARS-CoV-2 from Urine of a COVID-19 Patient. Emerg Microbes Infect. 2020 Apr 28:1-8. (IF=8.4)
12、Sun J#, Zhuang Z#, Zheng J#, Li K#, Wong RL#, Liu D#, Huang J#, He J#, Zhu A#, Zhao J#, Li X#, Xi Y#, Chen R, Alshukairi AN, Chen Z, Zhang Z, Chen C, Huang X, Li F, Lai X, Chen D, Wen L, Zhuo J, Zhang Y, Wang Y, Huang S, Dai J, Shi Y, Zheng K, Leidinger MR, Chen J, Li Y, Zhong N, Meyerholz DK, McCray PB Jr*, Perlman S*, Zhao J*. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 Jun 10:S0092-8674(20)30741-8. (IF=45.5)
周芸
